Presenter Speech
Yigal Nochomovitz (Analysts)
Great. So welcome, everyone, to the Summit Therapeutics session. Yigal Nochomovitz, biotech analyst here at Citi. We launched coverage on Summit just
B
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.50 USD | +1.94% |
|
+2.60% | +14.88% |
Jan. 13 | Summit Therapeutics Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:00 PM | |
Jan. 08 | Truist Initiates Summit Therapeutics at Buy With $35 Price Target | MT |
Presenter Speech
Yigal Nochomovitz (Analysts)
Great. So welcome, everyone, to the Summit Therapeutics session. Yigal Nochomovitz, biotech analyst here at Citi. We launched coverage on Summit just
B